Effects of Late Administration of Immunoglobulin on Experimental Atherosclerosis in Apolipoprotein E-Deficient Mice

  • Okabe Taka-aki
    Department of Cadiovascular Medicine, Graduate School of Medicine, Kyoto University
  • Kishimoto Chiharu
    Department of Cadiovascular Medicine, Graduate School of Medicine, Kyoto University
  • Shimada Kana
    Department of Cadiovascular Medicine, Graduate School of Medicine, Kyoto University
  • Murayama Toshinori
    Department of Cadiovascular Medicine, Graduate School of Medicine, Kyoto University
  • Yokode Masayuki
    Department of Cadiovascular Medicine, Graduate School of Medicine, Kyoto University
  • Kita Toru
    Department of Cadiovascular Medicine, Graduate School of Medicine, Kyoto University

この論文をさがす

抄録

Background Although immunoglobulin treatment, beginning simultaneously with the initiation of atherosclerosis, suppresses experimental atherosclerosis in apolipoprotein E-deficient mice, it remains unclear whether the treatment at a subsequent stage of atherosclerosis would be effective. Methods and Results Experimental atherosclerosis was induced in mice fed a high-fat diet containing 0.3% cholesterol. After confirming the presence of atherosclerotic lesions at 11 weeks, the mice were treated with an intraperitoneal injection of either intact type of immunoglobulin or F(ab')2 fragments of immunoglobulin (both, 1 g · kg -1 · day-1) on alternate days over 4 weeks. Fatty streak lesion was suppressed by intact immunoglobulin administration, but not by F(ab')2 fragments of immunoglobulin. Immunohistochemical analysis showed that macrophage and CD4+ T-cell accumulation in the fatty streak lesion was suppressed in mice that received intact immunoglobulin but not in those that received F(ab')2 fragments. Conclusions Immunoglobulin treatment, even at a later stage of atherosclerosis, suppresses the development of lesions associated with the reduced expression of immune-activated cells in fatty streak plaques, demonstrating the benefits of immunoglobulin therapy for prevention of atherosclerosis. (Circ J 2005; 69: 1543 - 1546)<br>

収録刊行物

  • Circulation Journal

    Circulation Journal 69 (12), 1543-1546, 2005

    一般社団法人 日本循環器学会

被引用文献 (5)*注記

もっと見る

参考文献 (23)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ